Press Releases
Yamaha Motor Co., Ltd. (Tokyo: 7272) will participate in the Japan Mobility Show 2025 organized by the Japan Automobile Manufacturers Association, Inc., which is scheduled to be held at the Tokyo Big Sight from October 29 to November 9 (Press days: Oct. 29-30; General public days: Oct. 31-Nov. 9), with the theme of "Feel. Move."
By Yamaha Motor Co., Ltd. · Via Business Wire · November 3, 2025
Eric Jing, Chairman of Ant Group, reaffirmed Ant’s commitment to deepening cross-sector collaboration on regulated AI and tokenization innovation in the territory, and to expanding its cross-border payment and trade financing services to support Hong Kong’s initiative to help Chinese businesses go global.
By Ant Group · Via Business Wire · November 3, 2025
Fal.Con Europe 2025, Barcelona-- CrowdStrike (NASDAQ: CRWD) today released the 2025 European Threat Landscape Report, revealing that European organizations accounted for nearly 22% of global ransomware and extortion victims — second only to North America. Ransomware operations are moving faster than ever, with CrowdStrike observing adversary groups like SCATTERED SPIDER increasing ransomware deployment speed by 48%, with the average attack now taking just 24 hours.
By CrowdStrike · Via Business Wire · November 3, 2025
ARCHOS, partenaire technologique de la Paris Investor Week 2025
Via Actus News · November 3, 2025
OCTOPUS BIOSAFETY : OCTOPUS et TAW annonce un partenariat stratégique avec EXCELCAR pour accélérer la robotisation de la propreté dans l'industrie.
Via Actus News · November 3, 2025
Fnezx hereby issues this notice to users, affirming compliance as the fundamental principle of platform operations and embedding “compliance as product” into organizational structure, procedural systems, and performance evaluation. The platform establishes standardized control points at critical stages such as account opening, transaction matching, deposit/withdrawal, and partnership onboarding. Through tiered identity verification, address validation, transaction profiling, and risk limits, Fnezx ensures daily governance that is traceable, verifiable, and accountable. The legal and policy research teams monitor regulations across multiple jurisdictions, maintain compliance checklists, and periodically calibrate business processes and document templates to prevent misinterpretation and execution gaps.
Via Binary News Network · November 3, 2025
SPM Instrument, a global leader in condition monitoring, is taking the next step in its mission to empower industries with knowledge and tools that ensure reliability and performance. SPM Academy Inc., based in the U.S., will serve as a worldwide hub for vibration training and certification, strengthening industrial reliability expertise across sectors.
By SPM International · Via Business Wire · November 3, 2025
By VIVOLTA · Via GlobeNewswire · November 3, 2025
WALLIX : Excellent third-quarter business momentum 2025 targets confirmed
Via Actus News · November 3, 2025
WALLIX : Excellente dynamique de l'activité au troisième trimestre - Objectifs 2025 confirmés
Via Actus News · November 3, 2025
LONDON and MILAN, Nov. 03, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 million (€122 million) Series B financing round.
By AAVantgarde · Via GlobeNewswire · November 3, 2025
Press ReleaseNokia and OneLayer partner to accelerate secure private 5G/LTE adoption for utilities
By Nokia Oyj · Via GlobeNewswire · November 3, 2025
Seasoned executives bring 40+ years of combined leadership across finance and go-to-market functions and enterprise software technology companies. Appointments advance Darktrace’s strategy to deepen customer value, scale its global operations, and deliver sustainable growth.
By Darktrace · Via GlobeNewswire · November 3, 2025
Singapore, Singapore--(Newsfile Corp. - November 3, 2025) - Sedifly, an EdTech startup, has closed a 3x oversubscribed six-figure pre-seed...
Via Newsfile · November 3, 2025
Sheridan, Wyoming--(Newsfile Corp. - November 3, 2025) - Luxintravels VIP, a private invitation only platform for discerning global travelers, is...
Via Newsfile · November 3, 2025
Shenzhen, China--(Newsfile Corp. - November 3, 2025) - Recently, Geekvape has once again captured worldwide attention with its outstanding R&D...
Via Newsfile · November 3, 2025
Garfield Project - Precious Metal Exploration Update
Via ACCESS Newswire · November 3, 2025
Mr. Michael X. Schlumpberger appointment to the Board
Via ACCESS Newswire · November 3, 2025
Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and operating results for the third quarter of 2025. For the quarter, the Company generated a net loss of $124 million, or $0.26 per diluted share. When adjusted for certain items that impact the comparability of results, the Company generated an adjusted net loss(1) of $72 million, or $0.15 per diluted share for the third quarter of 2025.
By Kosmos Energy Ltd. · Via Business Wire · November 3, 2025
Schiphol, November 3, 2025 - Aegon announces today that David Herzog, who was appointed as a member of the Board of Directors (BoD) at Aegon’s 2025 Annual General Meeting of shareholders (AGM), will succeed William Connelly as Chairman of the BoD as of November 13, 2025. In line with previous announcements, Mr Connelly will retire as Chairman and member of the BoD on the same date.
By Aegon Ltd. · Via GlobeNewswire · November 3, 2025
SAGUENAY, Quebec and ZUG, Switzerland, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Eder Therapeutics, a Canadian biopharmaceutical company focused on rare genetic disorders and XCubeBio AG, a biotechnology platform company focused on accelerating successful international market entry for innovative therapeutics, today announced their intention to form a jointly owned entity to coordinate clinical development and regional engagement across Europe and select international markets.
By XCubeBio · Via GlobeNewswire · November 3, 2025
Xpansiv® Limited (“Xpansiv”) and Evident Group Limited (“Evident”) today announced an agreement uniting their complementary registry and infrastructure capabilities to support the continued growth of the global renewable energy markets.
By Xpansiv Limited · Via Business Wire · November 3, 2025
Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of a new syringe for its category-leading hyaluronic acid (HA) brand BELOTERO®. The new syringe is ergonomically engineered to elevate the treatment experience, offering greater precision, comfort, and ease of use. The new syringe will launch first in Europe and then will expand to markets worldwide.
By Merz Aesthetics · Via Business Wire · November 3, 2025
A new study by Accenture (NYSE: ACN) has found that European organizations are placing greater emphasis on maintaining control over data and infrastructure which is likely to accelerate the demand for sovereign AI.
By Accenture · Via Business Wire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds WPP plc (“WPP” or the “Company”) (NYSE: WPP) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Fly-E Group, Inc. (“Fly-E” or the “Company”) (NASDAQ: FLYE) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds V.F. Corporation (“VFC” or the “Company”) (NYSE: VFC) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
By Bernstein Liebhard LLP · Via GlobeNewswire · November 3, 2025
BlockWoods is a leading Crypto Marketing agency with creative marketing experts to scale your business. Join hands with us to emerge as an iconic brand.
Via GlobePRwire · November 3, 2025
BlockWoods is a leading Crypto Marketing agency with creative marketing experts to scale your business. Join hands with us to emerge as an iconic brand.
Via GlobePRwire · November 3, 2025
Every day; when you check your email on your commute, when you scroll through social media on your lunch break, when you're queuing at the supermarket, when you glance at the screen while waiting for your drink at the coffee shop, or when you're standing in line at the store - all of these little everyday moments where your phone could be doing something more important at the same time, can become valuable opportunities to earn cryptocurrency and build wealth for your future.
Via GlobePRwire · November 3, 2025
BlockWoods is a leading Crypto Marketing agency with creative marketing experts to scale your business. Join hands with us to emerge as an iconic brand.
Via GlobePRwire · November 3, 2025
In 2025, IEO Crypto Whales officially announced the launch of its five core tokens: ROAU, JSUE, LITK, AIJ, and SBTE.
Via GlobePRwire · November 3, 2025
Fibroid Institute Texas announces that Dallas fibroid doctors Suzanne Slonim, MD and Cathryn Shaw, MD, are recognized among D Magazine’s Best Doctors in 2025. This is the tenth year Dr. Slonim has been named and Dr. Shaw’s fifth year.
Via Press Release Distribution Service · November 3, 2025
NewMediaLocal announces an AI-powered digital media production platform offering automated podcast, video, and article creation services for business owners. The system combines professional studio facilities with AI technology to help companies produce authority content at scale.
Via Press Release Distribution Service · November 3, 2025
Singapore, Singapore--(Newsfile Corp. - November 3, 2025) - FurGPT (FGPT), the decentralized AI pet companion platform, announced preparations for its...
Via Newsfile · November 3, 2025
San Antonio, Texas--(Newsfile Corp. - November 3, 2025) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the...
Via Newsfile · November 3, 2025
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in nearly 1 billion devices, is announcing that it has shipped the AI Virtual Smart Sensor Platform™ on four smartphone models in October 2025. Vivo launched two smartphones: the vivo V60 Lite 5G and V60 Lite smartphones. Xiaomi announced one smartphone: the Xiaomi 15T smartphone. TCL, Elliptic Labs’ newest smartphone customer, shipped one smartphone: the NxtPaper 60 Ultra smartphone. For 2025 year-to-date, Elliptic Labs has launched on a total of 58 smartphone models.
By Elliptic Labs · Via Business Wire · November 3, 2025
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today statistically significant and clinically meaningful results from the Phase III ALLEGORY study of Gazyva® (obinutuzumab) in adults with systemic lupus erythematosus (SLE) on standard therapy. The study met its primary endpoint showing a higher percentage of people achieved a minimum four-point improvement in SLE Responder Index 4 (SRI-4) at one year (52 weeks) with Gazyva versus standard therapy. SRI is a tool that assesses changes in disease severity, symptoms and physical condition to indicate whether treatment is effective at controlling disease activity. All key secondary endpoints were also met. No new safety signals were identified, and safety was in line with the well-characterized profile of Gazyva.
By Genentech · Via Business Wire · November 3, 2025
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present further preclinical proof-of-concept data on its logic-gated CD3 Switch-DARPin T cell engager (TCE) with CD2 co-stimulation in a poster at the Society for Immunotherapy of Cancer (SITC) 2025 meeting, taking place in National Harbor, MD, USA from November 5-9.
By Molecular Partners · Via GlobeNewswire · November 3, 2025
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present updated data from a Phase 1/2a trial of MP0533, a novel, multispecific T cell engager for acute myeloid leukemia (AML) patients, in a poster at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place December 6-9, 2025, in Orlando, Florida, and online.
By Molecular Partners · Via GlobeNewswire · November 3, 2025
With holiday season approaching, The Silver Clover & Co. presents a compelling case for jewelry as the ultimate meaningful gift through its innovative approach combining timeless pieces, personalized message cards, and luxury presentation packaging. The emerging jewelry retailer addresses common holiday gift-giving challenges by transforming beautiful accessories into complete storytelling experiences that recipients will treasure long after seasonal decorations are stored away.
Via AB Newswire · November 3, 2025
Swiss-Korean student Joschua Wyrsch is reshaping global understanding with a focus on truth, empathy, and cultural dialogue. He advocates for a future generation of diplomats who prioritize human connection over political power.
Via Press Release Distribution Service · November 3, 2025
Joint Development Agreement will establish a foundation for ultra-high energy density microbatteries
By Ensurge Micropower ASA · Via GlobeNewswire · November 3, 2025
DNOW Inc. (NYSE: DNOW) has scheduled a conference call to discuss the results for the third quarter of 2025 on Wednesday, November 5, 2025, at 8:00 am (US Central Time). Financial results for the third quarter ending September 30, 2025, are expected to be released that morning before the market opens.
By DNOW Inc. · Via Business Wire · November 3, 2025